← Back
Data updated: Mar 10, 2026
CHIESI FARMACEUTICI SPA
RespiratoryDermatologyCardiovascular
CHIESI FARMACEUTICI SPA is a biotechnology company focused on Respiratory, Dermatology, Cardiovascular. Key products include MYALEPT.
2014
Since
3
Drugs
-
Trials
1
Approved (2yr)
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Respiratory 93%
0 drugs Phase 3: 16 Phase 2: 14 Phase 1: 26
Dermatology 3%
0 drugs Phase 3: 1
Cardiovascular 3%
0 drugs Phase 3: 1
Gastroenterology 1%
0 drugs Phase 1: 1
Pipeline Strength Pro
Loading...
Competitors Pro
APOTHECON specialty
Dermatology, Cardiovascular, Gastroenterology, Respiratory
BAUSCH specialty
Dermatology, Cardiovascular, Gastroenterology
COREPHARMA other
Cardiovascular, Respiratory, Gastroenterology, Dermatology
CHIESI big-pharma
Respiratory, Cardiovascular, Dermatology, Gastroenterology
Pfizer big-pharma
Dermatology, Gastroenterology